88 related articles for article (PubMed ID: 26681215)
21. Association between N-Acetyltransferase 2 Polymorphism and Bladder Cancer Risk: a Meta-Analysis in a Single Ethnic Group.
Xu WJ; Wen LP; Jiang XX; Ye LY; Meng FH; Guan S; Qian YJ; Wei JF
Clin Lab; 2017 Feb; 63(2):287-293. PubMed ID: 28182356
[TBL] [Abstract][Full Text] [Related]
22. Impact of N-acetyltransferase polymorphism (NAT2) in hepatocellular carcinoma (HCC)--an investigation in a department of surgical medicine.
Farker K; Schotte U; Scheele J; Hoffmann A
Exp Toxicol Pathol; 2003 Jun; 54(5-6):387-91. PubMed ID: 12877350
[TBL] [Abstract][Full Text] [Related]
23. Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis.
Ambrosone CB; Kropp S; Yang J; Yao S; Shields PG; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):15-26. PubMed ID: 18187392
[TBL] [Abstract][Full Text] [Related]
24. NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population.
Marcus PM; Vineis P; Rothman N
Pharmacogenetics; 2000 Mar; 10(2):115-22. PubMed ID: 10761999
[TBL] [Abstract][Full Text] [Related]
25. NAT2 slow acetylator genotype as an important modifier of breast cancer risk.
Sillanpää P; Hirvonen A; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Mitrunen K
Int J Cancer; 2005 Apr; 114(4):579-84. PubMed ID: 15609332
[TBL] [Abstract][Full Text] [Related]
26. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.
Selinski S; Blaszkewicz M; Ickstadt K; Hengstler JG; Golka K
Arch Toxicol; 2013 Dec; 87(12):2129-39. PubMed ID: 24221535
[TBL] [Abstract][Full Text] [Related]
27. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
[TBL] [Abstract][Full Text] [Related]
28. Association of genetic polymorphisms of N-acetyltransferase 2 and susceptibility to esophageal cancer in north Indian population.
Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
Cancer Invest; 2007 Aug; 25(5):340-6. PubMed ID: 17661210
[TBL] [Abstract][Full Text] [Related]
29. NAT2 gene polymorphisms and endometriosis risk: A PRISMA-compliant meta-analysis.
Wei Z; Zhang M; Zhang X; Yi M; Xia X; Fang X
PLoS One; 2019; 14(12):e0227043. PubMed ID: 31881062
[TBL] [Abstract][Full Text] [Related]
30. N-acetyltransferase 2 status and gastric cancer risk: a meta-analysis.
Yu J; Deng Y; Chen JP
Tumour Biol; 2014 Jul; 35(7):6861-5. PubMed ID: 25051916
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer.
Zhou W; Liu G; Thurston SW; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):15-21. PubMed ID: 11815396
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators.
Majumder M; Sikdar N; Ghosh S; Roy B
Int J Cancer; 2007 May; 120(10):2148-56. PubMed ID: 17290401
[TBL] [Abstract][Full Text] [Related]
33. N-acetyltransferase-2 genotypes among Jordanian patients with diabetes mellitus.
Irshaid YM; Abujbara MA; Ajlouni KM; El-Khateeb M; Jarrar YB
Int J Clin Pharmacol Ther; 2013 Jul; 51(7):593-9. PubMed ID: 23587153
[TBL] [Abstract][Full Text] [Related]
34. N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinoma.
Ladero JM; Agúndez JA; Olivera M; Lozano L; Rodríguez-Lescure A; Diaz-Rubio M; Benítez J
Eur J Clin Pharmacol; 2002 May; 58(2):115-8. PubMed ID: 12012143
[TBL] [Abstract][Full Text] [Related]
35. Impact of interaction of polymorphic forms of p53 codon 72 and N-acetylation gene (NAT2) on the risk of lung cancer in the North Indian population.
Sobti RC; Kaur P; Kaur S; Janmeja AK; Jindal SK; Kishan J; Raimondi S
DNA Cell Biol; 2009 Sep; 28(9):443-9. PubMed ID: 19558213
[TBL] [Abstract][Full Text] [Related]
36. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk.
Chang-Claude J; Kropp S; Jäger B; Bartsch H; Risch A
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):698-704. PubMed ID: 12163321
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: a pilot study in north Indian population.
Srivastava DS; Mittal RD
BMC Urol; 2005 Aug; 5():12. PubMed ID: 16083506
[TBL] [Abstract][Full Text] [Related]
38. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer.
Cascorbi I; Brockmöller J; Mrozikiewicz PM; Bauer S; Loddenkemper R; Roots I
Cancer Res; 1996 Sep; 56(17):3961-6. PubMed ID: 8752164
[TBL] [Abstract][Full Text] [Related]
39. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
[TBL] [Abstract][Full Text] [Related]
40. NAT2 slow acetylation genotypes contribute to asthma risk among Caucasians: evidence from 946 cases and 1,091 controls.
Wang Y; Zhang Q; Zhang M; Wang C
Mol Biol Rep; 2014 Mar; 41(3):1849-55. PubMed ID: 24442317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
